ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 25 No. 4 | April 26, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

June 12, 1992

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994